Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myelomaOliver Van Oekelen, Samir Parekh, Charles Gleason et al.|Cancer Cell|2021Cited by 216
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapyOliver Van Oekelen, Samir Parekh, Gunjan L. Shah et al.|Blood|2022Cited by 103
Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myelomaAdolfo Aleman, Bhaskar Upadhyaya, Kevin Tuballes et al.|Cancer Cell|2021Cited by 76
Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patientsAdolfo Aleman, Samir Parekh, Oliver Van Oekelen et al.|Cancer Cell|2022Cited by 38